TRACK BRANDS ON AI
Monitor your brand, company, or product's online reputation in AI responses
Searching...
Loading...
It's taking longer than usual, we might be experiencing higher load.
Give it a few more seconds or try again in a moment.
Give it a few more seconds or try again in a moment.
Searching...
Loading...
What does AI know about Acadia Pharmaceuticals Inc?
What does OpenAI free version (gpt-3.5-turbo) know about Acadia Pharmaceuticals Inc?
Last request | 17.12.2023
(There is a high chance that below response is an AI hallucination) |
Well Known | No |
Description | Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders. |
Most Notable Achievements | Acadia Pharmaceuticals Inc has a strong pipeline of potential treatments for neurological disorders. |
The Most Negative Fact | Acadia Pharmaceuticals Inc has yet to bring any of its products to market. |
Competition | None |
Share with friends |
Register your email below to unlock features!
Don't like the AI answers? Who can help me Change them?
What does OpenAI paid version (gpt-4) know about Acadia Pharmaceuticals Inc?
Request date | |
Well Known | No |
Description | Acadia Pharmaceuticals Inc is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. |
Most Notable Achievements | Their drug, Nuplazid, was the first and only FDA-approved treatment for hallucinations and delusions associated with Parkinson's disease psychosis. |
The Most Negative Fact | The company has faced controversy and criticism over the safety and efficacy of Nuplazid, as well as allegations of improper marketing practices. |
Competition | None |
Share with friends |
What does Google AI (PaLM) know about Acadia Pharmaceuticals Inc?
Last request | 17.12.2023 |
Well Known | yes |
Description | Acadia Pharmaceuticals Inc. is a biopharmaceutical company that develops and commercializes treatments for central nervous system disorders. |
Most Notable Achievements | The company's lead product, NUPLAZID, is a treatment for schizophrenia. |
The Most Negative Fact | The company has been criticized for its high prices for its products. |
Competition | None |
What does Microsoft Bing AI know about Acadia Pharmaceuticals Inc?
Well Known | No |
Description | so mris oihniepdmm sr.inddupaa ohtmtpel cmalsciid oaanAdb a mm tie mtcaneodvcctrea ev nssiciteiilnosodea m iar o teaenlnuyoo ec PcuceI stfsv edneor rceycaanhe lizi lvfdcannosstscmdaeairnuuarendet e |
Most Notable Achievements | ttaneinm taIoaAlcorfnl retassntcp rr o irunugcaoec .hatmrfocdieisi seaetia l odndheiograapl ssPlpe |
The Most Negative Fact | c smng k IehPodf aciaa ounett. ueis Aocatay rmsstci rtrdtyplbc hatn aia ro |
Competition | neoN |